Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
12/08/2005 | WO2005116191A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
12/08/2005 | WO2005116190A1 Method for obtaining a product from a vegetable raw material which is used for extracting active compounds of topic cosmetic or pharmaceutical product |
12/08/2005 | WO2005116189A2 Compositions and use of inflammation-20 (inf-20) gene |
12/08/2005 | WO2005116184A1 Biosample manipulation apparatus |
12/08/2005 | WO2005116080A1 Antibody specific for alkylphenol and use thereof |
12/08/2005 | WO2005116079A1 Antibody capable of recognizing ligand of allylhydrocarbon receptor and use thereof |
12/08/2005 | WO2005116073A2 Pdx1 expressing endoderm |
12/08/2005 | WO2005116056A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein |
12/08/2005 | WO2005115621A1 Identification of biological samples |
12/08/2005 | WO2005115601A1 A device for controlling and regulating the physical-biochemical condition of a liquid mixture |
12/08/2005 | WO2005115447A2 Human anti-cancer immunotherapy |
12/08/2005 | WO2005115432A2 Treatment of ocular diseases and disorders using lantibiotic compositions |
12/08/2005 | WO2005115419A1 USES OF BISPECIFIC ANTIBODY (Biab) COATED DENDRITIC CELLS PULSED WITH ANTIGENS |
12/08/2005 | WO2005115141A1 Preservative solution for cells, tissues and organs comprising rare sugar and presercation method with the use of the same |
12/08/2005 | WO2005115133A1 Method of gene introduction in in-vivo spermatogenic cell |
12/08/2005 | WO2005095590A3 Sperm suspensions for sorting into x or y chromosome-bearing enriched populations |
12/08/2005 | WO2005067410A3 Synthetic nucleic acids from aquatic species |
12/08/2005 | WO2005054447A3 Müller stem cells |
12/08/2005 | WO2005045035A3 RNA INTERFERENCE MEDIATED INHIBITION OF NOGO AND NOGO RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
12/08/2005 | WO2005019408A3 Plants resistant to cytoplasm-feeding parasites |
12/08/2005 | WO2005001054A3 Methods of producing neurons |
12/08/2005 | WO2004069172A3 Multilineage-inducible cells and uses thereof |
12/08/2005 | WO2002066494A3 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade |
12/08/2005 | US20050273889 Inbred corn line PH8TN |
12/08/2005 | US20050273887 Stress resistant plants |
12/08/2005 | US20050273885 Synthesis of long-chain polyunsaturated fatty acids by recombinant cells |
12/08/2005 | US20050273884 PUFA polyketide synthase systems and uses thereof |
12/08/2005 | US20050273883 Pufa polyketide synthase systems and uses thereof |
12/08/2005 | US20050273879 Phytate polynucleotides and methods of use |
12/08/2005 | US20050273878 Inbred corn line n61060 |
12/08/2005 | US20050273877 Inbred corn line m10138 |
12/08/2005 | US20050273876 Inbred corn line w16090 |
12/08/2005 | US20050273873 Genomic modification |
12/08/2005 | US20050273869 Plasmids and phages for homologous recombination and methods of use |
12/08/2005 | US20050273868 Methods and compositions for enhancing RISC activity in vitro and in vivo |
12/08/2005 | US20050272918 Method of treating allergy using antibody against human interleukin-5 receptor alpha chain |
12/08/2005 | US20050272915 Skrp, astray, string, vacm associated with metabolic control |
12/08/2005 | US20050272633 Derivatives of the nf-kappab inducing enzyme, their preparation and use |
12/08/2005 | US20050272155 Methods and compositions for enhancing cell adhesion properties |
12/08/2005 | US20050272153 Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal |
12/08/2005 | US20050272152 Nutrient broth for expanding glycoprotein (CD34) expressing cells; reconstituting, repairing and regenerating tissue damage; tissue engineering |
12/08/2005 | US20050272151 Dendritic cell line |
12/08/2005 | US20050272150 culturing the cells in a medium conditioned by prostate epithelial cells; shows that keratinocytes can be replaced by another cell type that produces the same or similar signaling molecule in order to obtain the response in a mesenchymal cell |
12/08/2005 | US20050272149 Therapeutic delivery of adenosine into a tissue |
12/08/2005 | US20050272148 Method of collecting placental stem cells |
12/08/2005 | US20050272147 Methods for ex vivo propagation of somatic hair follicle stem cells |
12/08/2005 | US20050272128 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
12/08/2005 | US20050272127 Antibody against an angiogenesis-inhibiting peptide homologous to human ChM1L chondromodulin-I (ChM-I); hybridomas; diagnostic kits; controlling angiogenesis |
12/08/2005 | US20050272124 Polypeptide production in animal cell culture |
12/08/2005 | US20050272120 Compositions and methods for the diagnosis and treatment of tumor |
12/08/2005 | US20050272077 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
12/08/2005 | US20050272058 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
12/08/2005 | US20050271738 Methods and compositions for treating tissue defects using pulsed electromagnetic field stimulus |
12/08/2005 | US20050271688 Modified vaccinia ankara virus variant |
12/08/2005 | US20050271685 Cellular permissivity factor for viruses and uses thereof |
12/08/2005 | US20050271664 Antibodies for inhibiting blood coagulation and methods of use thereof |
12/08/2005 | US20050271662 Proteins, polypeptides, fusion proteins, polynucleotides, vectors, host cells, antibodies or antigen binding portions; diagnosis and treatment of canine or feline B-cell lymphoma, immune-mediated hemolytic anemia or thrombocytopenia, and systemic lupus erythematosus |
12/08/2005 | US20050271655 Nogo receptor antagonists |
12/08/2005 | US20050271644 Vitamin K epoxide recycling polypeptide VKORC1, a therapeutic target of coumarin and their derivatives |
12/08/2005 | US20050271639 Genetically engineered cells for therapeutic applications |
12/08/2005 | US20050271638 BMP pathway methods and compositions |
12/08/2005 | US20050271637 BMP-2 estrogen responsive element and methods of using the same |
12/08/2005 | US20050271635 For repairing or augmenting tissues |
12/08/2005 | US20050271634 Growth factor therapy mobilization of stem cells into the peripheral blood |
12/08/2005 | US20050271633 Issue defect augmentation and repair with in vitro cultured fibroblasts |
12/08/2005 | US20050271632 Methods of modulating hair growth |
12/08/2005 | US20050271631 Material compositions and related systems and methods for treating cardiac conditions |
12/08/2005 | US20050271628 Negative-sense RNA virus vector for nerve cell |
12/08/2005 | US20050271627 Calbindin-D28K protection against glucocorticoid induced cell death |
12/08/2005 | DE102005018643A1 Osteogenic matrix composite used for coating tissue engineering implants or scaffolds, comprises non-collagen extracellular matrix component integrated in non-crosslinked collagen fibrils |
12/08/2005 | DE102004024635A1 Verfahren zur Herstellung von Formkörpern auf Basis von vernetzter Gelatine A process for the production of moldings based on crosslinked gelatin |
12/08/2005 | CA2777821A1 Mhc molecule-binding tumor-associated peptides |
12/08/2005 | CA2772033A1 Compositions and methods for bone formation and remodeling |
12/08/2005 | CA2772029A1 Compositions and methods for bone formation and remodeling |
12/08/2005 | CA2771940A1 Compositions and methods for bone formation and remodeling |
12/08/2005 | CA2590553A1 Method for identifying pde5-modulators |
12/08/2005 | CA2567952A1 Oral anti-protozoiasis vaccines based on transgenic plants |
12/08/2005 | CA2567942A1 Hla-a24- or hla-a2-binding peptide of parathyroid hormone-related protein |
12/08/2005 | CA2567814A1 Antibodies as t cell receptor mimics, methods of production and uses thereof |
12/08/2005 | CA2566473A1 Uses of bispecific antibody (biab) coated dendritic cells pulsed with antigens |
12/08/2005 | CA2565545A1 Treatment of ocular diseases and disorders using lantibiotic compositions |
12/08/2005 | CA2564114A1 Pdx1 expressing endoderm |
12/08/2005 | CA2563314A1 Fcyriib-specific antibodies and methods of use thereof |
12/07/2005 | EP1602729A2 Methods for producing transgenic plants |
12/07/2005 | EP1602668A1 Monoclonal antibodies specific to VEGF receptors and uses thereof |
12/07/2005 | EP1602666A1 Novel protein and its dna |
12/07/2005 | EP1602383A1 Cell sheets for ectocornea formation, method of producing the same and method of using the same |
12/07/2005 | EP1601967A2 Identification of antigen epitopes |
12/07/2005 | EP1601776A2 Expression vectors comprising the mcmv ie2 promoter |
12/07/2005 | EP1601775A1 Animal model for the fast identification of pharmaceutical active compounds in vivo |
12/07/2005 | EP1601763A2 Cell culture |
12/07/2005 | EP1601762A1 Extraction and use of collagen extracted from either a sea mammal or a bony fish |
12/07/2005 | EP1601759A2 Expansion of renewable stem cell populations using modulators of pi 3-kinase |
12/07/2005 | EP1601687A1 Methods for increasing the proliferation of b cells |
12/07/2005 | EP1601390A2 Scaffold for cell growth and differentiation |
12/07/2005 | EP1601331A2 Il-2 transmembrane constructs |
12/07/2005 | EP1601248A2 Use of umbilical cord blood to treat individuals having a disease, disorder or condition |
12/07/2005 | EP1578983A3 Methods for regulating co-stimulatory molecule expression with reactive oxygen |
12/07/2005 | EP1423409A4 Gastrokines and derived peptides including inhibitors |
12/07/2005 | EP1266006B1 Production of recombinant muteins of blood clotting factor viii in human cell lines |